RenovoRx is seeking its first Medical Science Liaison (MSL) to serve as a scientific and clinical expert and build trusted relationships with healthcare professionals—primarily medical, surgical, and radiation oncologists—across academic and community settings. The MSL will help physicians and their staff become experts in the TAMP therapy platform, bridge scientific evidence and clinical practice, deliver medical education, and generate actionable field insights. The role reports to the Chief Medical Officer and partners with the management team and cross-functional colleagues. It is a high-visibility, field-based position requiring an entrepreneurial approach to identifying and gaining access to oncology decision-makers, engaging them in peer-to-peer discussions of Phase III data relative to the standard of care, and working closely alongside Sales. As Medical Affairs grows, the MSL may have the opportunity to help build and lead the field function. RenovoRx’s TAMP platform is designed to deliver therapeutic agents across the arterial wall near a tumor. RenovoCath is an FDA-cleared drug-delivery catheter in commercial use since December 2024. Intra-arterial gemcitabine (IAG) delivered via RenovoCath is investigational and has been evaluated in the Phase III TIGeR-PaC trial for locally advanced pancreatic cancer. The posting describes interim trial findings and a peer-reviewed pharmacokinetic/pharmacodynamic sub-study; scientific communications about the investigational product must remain non-promotional and compliant. The position is remote for candidates anywhere in the U.S. near a major airport and requires significant travel, approximately 14 days per month, to clinical sites, conferences, and internal meetings. Compensation is commensurate with experience and includes an annual bonus opportunity and stock options.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior